BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 -- Minoryx Therapeutics and Neuraxpharm Group, announce that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
Reneo Pharmaceuticals
Reneo Pharmaceuticals is a clinical-stage start-up company, co-founded by Pappas Capital, focused on developing treatments for rare metabolic disorders
